JPRN-UMIN000014328已完成1 期
Hypofractionated radiotherapy for low and intermediate-risk prostate cancer using robot-tracking stereotactic radiotherapy -phase I/II clinical trial- - Robot-tracking stereotactic radiotherapy for prostate cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Active double cancer 2) Uncontrollable DM 3) Impossible to stop anticoagulate drugs 4) Severe brain disease 5) Collagen disease 6) Previous pelvic surgery or radiotherapy 7) Previous TUR-P 8) Severe BPH or dysuria 9) Disagree to implant of metallic marker 10) Hormone therapy > 1 year 11) Castration-resistant prostate cancer 12) PSA >20 13) Physician-rated contraindication
研究者
相似试验
招募中
3 期
Standard moderately hypofractionated radiotherapy vs. ultra-hypofractionated focal lesion ablative microboost in prostate cancer, Hypo-FLAME 3.010038597prostate cancerNL-OMON56327Antoni van Leeuwenhoek Ziekenhuis352
已完成
2 期
Intensity-modulated, hypofractionated radiotherapy with scanning beam protons for locally advanced carcinoma of the prostate and localized carcinoma of the prostate with risk factors - a phase II studyC61Malignant neoplasm of prostateDRKS00011912Westdeutsches Protonentherapiezentrum Essen (WPE)133
招募中
2 期
Two-fraction Ultra-hypofractionated Radiotherapy with Focal Boost for low- and intermediate risk, localized prostate cancer (TURBO):phase II, randomized controlled clinical trialprostate adenocarcinoma100276561001818810036958prostate cancerNL-OMON56580niversitair Medisch Centrum Utrecht160
已完成
2 期
Hypofractionated stereotactic radiotherapy for large brain metastasesBrain metastasesJPRN-UMIN000010112Department of Radiology, Nagoya City University Graduate School of Medical Sciences90
进行中（未招募）
不适用
Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancerKCT0005443ational Cancer Center35